Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Teligent Pharma, Inc.
FDA Inspection
•Teligent Pharma, Inc.•August 31, 2021

Teligent Pharma, Inc. – FDA Inspection, Aug 31, 2021

Record Details

This FDA Inspection record concerns Teligent Pharma, Inc., with an inspection on August 31, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Teligent Pharma, Inc.
Inspection Date
August 31, 2021
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · eb729f01-1b0b-4787-bbb2-2ec0cd04754f

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1150271
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

15
  1. 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
  2. 21 CFR 211.188(b)(1)Dates not included for each significant step
  3. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  4. 21 CFR 211.137(a)Expiration date lacking
  5. 21 CFR 211.25(a)Training , Education , Experience overall
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  7. 21 CFR 211.160(a)Following/documenting laboratory controls
  8. 21 CFR 211.25(a)GMP Training Frequency
  9. 21 CFR 211.192Extent of discrepancy, failure investigations
  10. 21 CFR 211.194(a)(8)Second person sign off

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Teligent Pharma, Inc.

8
DateClassificationOfficeProject area
May 20, 2019Not classifiedNew Jersey District OfficeDrug Quality Assurance
October 19, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 22, 2016NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
December 19, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 2, 2012NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 8 other inspections on the company page
Other documents for Teligent Pharma, Inc.
  • FDA Inspection 1090090 - 2019-05-20
  • FDA Inspection 1032023 - 2017-10-19
  • FDA Inspection 956413 - 2016-01-22
  • FDA Inspection 859472 - 2013-12-19
  • FDA Inspection 765396 - 2012-02-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Teligent Pharma, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.